90EGP
- Active ingredient
- nevirapine
- Strength
- 200 mg
- Form
- tablet
- Manufacturer
- egpi
- Route
- oral.solid
Uses
Used in combination with other antiretroviral medicines for the treatment of HIV-1 infection.
Do not use if
Moderate to severe hepatic impairment, previous severe skin or liver reactions to nevirapine, or hypersensitivity.
Side effects
Rash, nausea, fatigue, liver abnormalities, and hypersensitivity reactions may occur.
Warnings
Severe and potentially fatal hepatotoxicity and skin reactions may occur, especially early in treatment.
How it works
Non-nucleoside reverse transcriptase inhibitor that suppresses HIV replication.
Storage
Store at room temperature in the original container.